BB
The startup develops a healthcare technology platform that utilizes gut hormones and natural hormone responses to enhance bone density in osteoporosis patients. By inhibiting bone resorption and promoting bone formation, their therapeutics aim to improve bone growth and reduce bone degradation.
Updated 3 months ago
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a healthcare technology platform that utilizes gut hormones and natural hormone responses to enhance bone density in osteoporosis patients. By inhibiting bone resorption and promoting bone formation, their therapeutics aim to improve bone growth and reduce bone degradation.